The Gut Microbiome of Adults With Type 1 Diabetes and Its Association With the Host Glycemic Control.


Journal

Diabetes care
ISSN: 1935-5548
Titre abrégé: Diabetes Care
Pays: United States
ID NLM: 7805975

Informations de publication

Date de publication:
01 03 2022
Historique:
received: 08 08 2021
accepted: 22 12 2021
pubmed: 20 1 2022
medline: 11 3 2022
entrez: 19 1 2022
Statut: ppublish

Résumé

Previous studies have demonstrated an association between gut microbiota composition and type 1 diabetes (T1D) pathogenesis. However, little is known about the composition and function of the gut microbiome in adults with longstanding T1D or its association with host glycemic control. We performed a metagenomic analysis of the gut microbiome obtained from fecal samples of 74 adults with T1D, 14.6 ± 9.6 years following diagnosis, and compared their microbial composition and function to 296 age-matched healthy control subjects (1:4 ratio). We further analyzed the association between microbial taxa and indices of glycemic control derived from continuous glucose monitoring measurements and blood tests and constructed a prediction model that solely takes microbiome features as input to evaluate the discriminative power of microbial composition for distinguishing individuals with T1D from control subjects. Adults with T1D had a distinct microbial signature that separated them from control subjects when using prediction algorithms on held-out subjects (area under the receiver operating characteristic curve = 0.89 ± 0.03). Linear discriminant analysis showed several bacterial species with significantly higher scores in T1D, including Prevotella copri and Eubacterium siraeum, and species with higher scores in control subjects, including Firmicutes bacterium and Faecalibacterium prausnitzii (P < 0.05, false discovery rate corrected for all). On the functional level, several metabolic pathways were significantly lower in adults with T1D. Several bacterial taxa and metabolic pathways were associated with the host's glycemic control. We identified a distinct gut microbial signature in adults with longstanding T1D and associations between microbial taxa, metabolic pathways, and glycemic control indices. Additional mechanistic studies are needed to identify the role of these bacteria for potential therapeutic strategies.

Identifiants

pubmed: 35045174
pii: 140931
doi: 10.2337/dc21-1656
doi:

Substances chimiques

Blood Glucose 0

Banques de données

ClinicalTrials.gov
['NCT02919839']
figshare
['10.2337/figshare.17430323']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

555-563

Informations de copyright

© 2022 by the American Diabetes Association.

Auteurs

Smadar Shilo (S)

Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.
Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Pediatric Diabetes Clinic, Institute of Diabetes, Endocrinology and Metabolism, Rambam Health Care Campus, Haifa, Israel.

Anastasia Godneva (A)

Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.
Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Marianna Rachmiel (M)

Pediatric Endocrinology Unit, Shamir Medical Center, Zerifin, Israel.
Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.

Tal Korem (T)

Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.
Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Department of Systems Biology, Columbia University, New York, NY.

Yuval Bussi (Y)

Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.
Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Dmitry Kolobkov (D)

Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.
Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Tal Karady (T)

Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.
Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Noam Bar (N)

Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.
Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Bat Chen Wolf (BC)

Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.
Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Yitav Glantz-Gashai (Y)

Pediatric Diabetes Clinic, Institute of Diabetes, Endocrinology and Metabolism, Rambam Health Care Campus, Haifa, Israel.

Michal Cohen (M)

Pediatric Diabetes Clinic, Institute of Diabetes, Endocrinology and Metabolism, Rambam Health Care Campus, Haifa, Israel.
Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.

Nehama Zuckerman-Levin (N)

Pediatric Diabetes Clinic, Institute of Diabetes, Endocrinology and Metabolism, Rambam Health Care Campus, Haifa, Israel.
Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.

Naim Shehadeh (N)

Pediatric Diabetes Clinic, Institute of Diabetes, Endocrinology and Metabolism, Rambam Health Care Campus, Haifa, Israel.
Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.

Noah Gruber (N)

Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.
Pediatric Endocrine and Diabetes Unit, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Ramat-Gan, Israel.

Neriya Levran (N)

Pediatric Endocrine and Diabetes Unit, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Ramat-Gan, Israel.
Robert H Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, Rehovot, Israel.

Shlomit Koren (S)

Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.
Diabetes Unit, Shamir Medical Center, Zerifin, Israel.

Adina Weinberger (A)

Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.
Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Orit Pinhas-Hamiel (O)

Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.
Pediatric Endocrine and Diabetes Unit, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Ramat-Gan, Israel.

Eran Segal (E)

Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.
Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH